Alpha Tau Medical Ltd.
DRTSW
Updated: 24/09/2026, 20:12:24
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.
No summaries found.
- Share price
- $3.91
- Market cap
- $1.51B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- Uzi Sofer
- Employees
- 112
- IPO date
- 06/03/2026
- Beta
- 1.185
- Last dividend
- $0.00
- Day range
- $0.33 – $4.00
- 52-week range
- $0.33 – $4.00
- 1-day performance
- -2.25%
- 1-year performance
- 1102.71%
- Current drawdown (1Y)
- -2.25%
- CIK
- 0001871321
- CUSIP
- M0740A116
- ISIN
- IL0011839466
- Created
- 07/12/2025, 03:38:50
- Last update
- 24/09/2026, 20:12:24
Track Alpha Tau Medical Ltd. with an AI analyst
See which prediction-market events move DRTSW, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.